Company / Depreciation & Amortization
NEPHROS INC Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$140.0K
FY2025
5-year range
$140.0K / $218.0K
FY2021-FY2025
Trend
-34.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $218,000 to $140,000 over the past 2 years.
Based on SEC 10-K filings.
$140,000 in FY2025 with a 5-year CAGR of -6.1%.
Improved from $218,000 to $140,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -13.7%
- 5-Year CAGR
- -6.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -6.1%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 34.6% year-over-year.
- Peak depreciation & amortization was recorded in FY2017.
- Lowest depreciation & amortization in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -5.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $140.0K | -34.6% |
| FY2024 | $214.0K | -1.8% |
| FY2023 | $218.0K | +0.0% |
| FY2022 | $218.0K | +13.5% |
| FY2021 | $192.0K | +0.0% |
| FY2020 | $192.0K | +3.2% |
| FY2019 | $186.0K | +14.1% |
| FY2018 | $163.0K | -29.1% |
| FY2017 | $230.0K | +1110.5% |
| FY2016 | $19.0K | +1800.0% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 28, 2026